ALT
Price
$5.50
Change
-$0.08 (-1.43%)
Updated
May 19 closing price
Capitalization
446.09M
79 days until earnings call
VKTX
Price
$27.81
Change
+$0.31 (+1.13%)
Updated
May 20, 11:52 AM (EDT)
Capitalization
3.09B
64 days until earnings call
Ad is loading...

ALT vs VKTX

Header iconALT vs VKTX Comparison
Open Charts ALT vs VKTXBanner chart's image
Altimmune
Price$5.50
Change-$0.08 (-1.43%)
Volume$1.5M
Capitalization446.09M
Viking Therapeutics
Price$27.81
Change+$0.31 (+1.13%)
Volume$300
Capitalization3.09B
ALT vs VKTX Comparison Chart
Loading...
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALT vs. VKTX commentary
May 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALT is a Hold and VKTX is a Hold.

Ad is loading...
COMPARISON
Comparison
May 20, 2025
Stock price -- (ALT: $5.50 vs. VKTX: $27.50)
Brand notoriety: ALT and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALT: 65% vs. VKTX: 61%
Market capitalization -- ALT: $446.09M vs. VKTX: $3.09B
ALT [@Biotechnology] is valued at $446.09M. VKTX’s [@Biotechnology] market capitalization is $3.09B. The market cap for tickers in the [@Biotechnology] industry ranges from $284.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALT’s FA Score shows that 0 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • ALT’s FA Score: 0 green, 5 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, VKTX is a better buy in the long-term than ALT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALT’s TA Score shows that 5 TA indicator(s) are bullish while VKTX’s TA Score has 6 bullish TA indicator(s).

  • ALT’s TA Score: 5 bullish, 5 bearish.
  • VKTX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, VKTX is a better buy in the short-term than ALT.

Price Growth

ALT (@Biotechnology) experienced а -8.49% price change this week, while VKTX (@Biotechnology) price change was -2.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.00%. For the same industry, the average monthly price growth was +10.20%, and the average quarterly price growth was -2.20%.

Reported Earning Dates

ALT is expected to report earnings on Aug 07, 2025.

VKTX is expected to report earnings on Jul 23, 2025.

Industries' Descriptions

@Biotechnology (+3.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($3.09B) has a higher market cap than ALT($446M). ALT YTD gains are higher at: -23.717 vs. VKTX (-31.660). ALT has higher annual earnings (EBITDA): -94.81M vs. VKTX (-171.93M). VKTX has more cash in the bank: 852M vs. ALT (132M). VKTX has less debt than ALT: VKTX (1M) vs ALT (1.68M). ALT has higher revenues than VKTX: ALT (20K) vs VKTX (0).
ALTVKTXALT / VKTX
Capitalization446M3.09B14%
EBITDA-94.81M-171.93M55%
Gain YTD-23.717-31.66075%
P/E RatioN/AN/A-
Revenue20K0-
Total Cash132M852M15%
Total Debt1.68M1M168%
FUNDAMENTALS RATINGS
ALT vs VKTX: Fundamental Ratings
ALT
VKTX
OUTLOOK RATING
1..100
819
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
44
Fair valued
PROFIT vs RISK RATING
1..100
8972
SMR RATING
1..100
9792
PRICE GROWTH RATING
1..100
5762
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VKTX's Valuation (44) in the Biotechnology industry is somewhat better than the same rating for ALT (97) in the Miscellaneous Commercial Services industry. This means that VKTX’s stock grew somewhat faster than ALT’s over the last 12 months.

VKTX's Profit vs Risk Rating (72) in the Biotechnology industry is in the same range as ALT (89) in the Miscellaneous Commercial Services industry. This means that VKTX’s stock grew similarly to ALT’s over the last 12 months.

VKTX's SMR Rating (92) in the Biotechnology industry is in the same range as ALT (97) in the Miscellaneous Commercial Services industry. This means that VKTX’s stock grew similarly to ALT’s over the last 12 months.

ALT's Price Growth Rating (57) in the Miscellaneous Commercial Services industry is in the same range as VKTX (62) in the Biotechnology industry. This means that ALT’s stock grew similarly to VKTX’s over the last 12 months.

ALT's P/E Growth Rating (100) in the Miscellaneous Commercial Services industry is in the same range as VKTX (100) in the Biotechnology industry. This means that ALT’s stock grew similarly to VKTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALTVKTX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 5 days ago
88%
Bearish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 13 days ago
83%
Bullish Trend 5 days ago
82%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 7 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Ad is loading...
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY594.850.65
+0.11%
SPDR® S&P 500® ETF
BTC.X105606.180000-839.828100
-0.79%
Bitcoin cryptocurrency
AAPL208.78-2.48
-1.17%
Apple
GME27.89-0.56
-1.97%
GameStop Corp
TSLA342.09-7.89
-2.25%
Tesla

ALT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALT has been loosely correlated with CRNX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ALT jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALT
1D Price
Change %
ALT100%
-1.43%
CRNX - ALT
50%
Loosely correlated
-0.93%
CLDX - ALT
46%
Loosely correlated
+2.25%
XNCR - ALT
46%
Loosely correlated
N/A
VKTX - ALT
46%
Loosely correlated
-3.27%
COGT - ALT
46%
Loosely correlated
+2.05%
More

VKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with KRYS. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
-3.27%
KRYS - VKTX
46%
Loosely correlated
+1.29%
CRNX - VKTX
45%
Loosely correlated
-0.93%
ALT - VKTX
45%
Loosely correlated
-1.43%
ROIV - VKTX
45%
Loosely correlated
+0.46%
MREO - VKTX
44%
Loosely correlated
+2.23%
More